English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Tools annual

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Presents the access of premium content as premium feature

Premium Content

Global: Zendy Plus annual

Global: Zendy Free Plan

The utility of matrix-assisted laser desorption mass spectrometry for characterizing products of in vitro processing of synthetic dynorphin A (Dyn A) peptides in biologic matrices is described. A series of laser desorption matrices were tested for their response to Dyn A (1-6), Dyn A (1-7), Dyn A (1-8), Dyn A (1-9), Dyn A (1-l0), Dyn A (1-13), Dyn A (2-17), and Dyn A (1-17). α-Cyano-4-hydroxycinnamic acid was chosen as a suitable matrix for subsequent studies. Mass spectra of dynorphin peptides indicated a good signal-to-noise response down to (1) 10 fmole of Dyn A (1-10) amide standard in aqueous acidic solution and (2) a concentration of 10(-7) M for seven dynorphin peptides spiked into human plasma. Two examples of the mass spectrometric analysis of the products of in vitro processing are presented: Dyn A (1-13) and Dyn A (1-17) in human blood. The presence and identity of processed peptides can be simply inferred from the molecular masses provided by the mass spectrometric measurement without extensive sample purification. A comparison of matrixassisted laser desorption mass spectrometry is made with high-performance liquid chromatography.

Matrix-Assisted Laser Desorption Mass Spectrometry of Biotransformation Products of Dynorphin A in Vitro